Companies

Protalix BioTherapeutics, Inc. (PLX) SEC filings

CIK 0001006281 · Biological Products, (No Diagnostic Substances) (SIC 2836) · NYSE · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)52.7 M47.6 M
Net income (USD)-14.9 M-27.6 M-6.5 M
Diluted EPS (USD/shares)-0.08-0.31

Latest filings

FiledFormDescriptionPeriod
2026-10-15SCHEDULE 13GSCHEDULE 13G
2026-09-09442026-09-03
2026-09-04442026-09-03
2026-09-04442026-09-03
2026-09-04442026-09-03
2026-09-04442026-09-03
2026-09-04442026-09-03
2026-09-04442026-09-03
2026-09-04442026-09-03
2026-09-04442026-09-03
2026-08-12S-8FORM S-8
2026-08-1210-Q10-Q2026-06-30
2026-08-128-K8-K items 2.02,9.012026-08-12
2026-07-29SCHEDULE 13GSCHEDULE 13G
2026-06-258-K8-K items 5.07,9.012026-06-25
2026-05-218-K8-K items 7.01,9.012026-05-21
2026-05-1310-Q10-Q2026-03-31
2026-05-138-K8-K items 2.02,9.012026-05-13
2026-04-30ARSARS2025-12-31
2026-04-30DEF 14ADEF 14A2026-06-25
2026-04-273/A3/A2025-08-24
2026-03-30SCHEDULE 13G/ASCHEDULE 13G/A
2026-03-1810-K10-K2025-12-31
2026-03-188-K8-K items 2.02,9.012026-03-18
2026-03-098-K8-K items 8.01,9.012026-03-09

Forms on file (last 1,000): 8-K 334, 4 178, 10-Q 67, SC 13G/A 46, 3 39, SC 13G 27, DEF 14A 26, 10QSB 25. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=PLX (0.002 USD), /gw/filings/filings?ticker=PLX&form=8-K, /gw/filings/facts?ticker=PLX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange